Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence
- PMID: 1748540
Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence
Abstract
In bioequivalence studies, the maximum concentration (Cmax) is shown to reflect not only the rate but also the extent of absorption. Cmax is highly correlated with the area under the curve (AUC) contrasting blood concentration with time. Therefore, use of the Cmax/AUC ratio is recommended for assessing the equivalence of absorption rates. The ratio is independent of both intrasubject variations and possible differences in the extent of absorption and reflects only the contrast between the absorption and disposition rate constants (ka/k).
Similar articles
-
Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulations.Int J Clin Pharmacol Ther. 1994 Jul;32(7):323-8. Int J Clin Pharmacol Ther. 1994. PMID: 7952792
-
Variation of Cmax and Cmax/AUC in investigations of bioequivalence.Int J Clin Pharmacol Ther Toxicol. 1993 Apr;31(4):184-9. Int J Clin Pharmacol Ther Toxicol. 1993. PMID: 8500920
-
Comparison of absorption rates in bioequivalence studies of immediate release drug formulations.Int J Clin Pharmacol Ther Toxicol. 1992 May;30(5):153-9. Int J Clin Pharmacol Ther Toxicol. 1992. PMID: 1592542
-
Measures of exposure versus measures of rate and extent of absorption.Clin Pharmacokinet. 2001;40(8):565-72. doi: 10.2165/00003088-200140080-00001. Clin Pharmacokinet. 2001. PMID: 11523723 Review.
-
Comparison of average and population bioequivalence approach.Int J Clin Pharmacol Ther. 2002 Sep;40(9):431-8. doi: 10.5414/cpp40431. Int J Clin Pharmacol Ther. 2002. PMID: 12358161 Review.
Cited by
-
Bioequivalence of controlled-release calcium antagonists.Clin Pharmacokinet. 1997 Jan;32(1):75-89. doi: 10.2165/00003088-199732010-00004. Clin Pharmacokinet. 1997. PMID: 9012557 Review.
-
Absorption rate vs. exposure: which is more useful for bioequivalence testing?Pharm Res. 1996 Mar;13(3):453-6. doi: 10.1023/a:1016061013606. Pharm Res. 1996. PMID: 8692741
-
Evaluation of the antimalarial activity of SAM13-2HCl with morpholine amide (SKM13 derivative) against antimalarial drug-resistant Plasmodium falciparum and Plasmodium berghei infected ICR mice.Parasites Hosts Dis. 2024 Feb;62(1):42-52. doi: 10.3347/PHD.23093. Epub 2024 Feb 23. Parasites Hosts Dis. 2024. PMID: 38443769 Free PMC article.
-
Formulation and pharmacokinetics of multi-layered matrix tablets: Biphasic delivery of diclofenac.Saudi Pharm J. 2017 Jul;25(5):688-695. doi: 10.1016/j.jsps.2016.10.004. Epub 2016 Oct 17. Saudi Pharm J. 2017. PMID: 28725140 Free PMC article.
-
Bioavailability of immediate- and extended-release formulations of glipizide in healthy male volunteers.Clin Pharmacokinet. 2006;45(3):317-24. doi: 10.2165/00003088-200645030-00007. Clin Pharmacokinet. 2006. PMID: 16509763 Clinical Trial.
MeSH terms
LinkOut - more resources
Other Literature Sources